Update on the management of status epilepticus

被引：0

作者：

Paris, Marco ^{[1
]}

Reddy, Ugan ^{[2
]}

机构：

[1] Natl Hosp Neurol & Neurosurg, Neurosurg & Neurocrit Care, London, England

[2] Natl Hosp Neurol & Neurosurg, Neurocrit Care & Neuroanaesthesia, London, England

来源：

ANAESTHESIA AND INTENSIVE CARE MEDICINE | 2021年 / 22卷 / 02期

关键词：

EEG monitoring; epilepsy; new anti-epileptic medication; refractory status epilepticus; status epilepticus;

D O I：

暂无

中图分类号：

R614 [麻醉学];

学科分类号：

100217 ;

摘要：

Status epilepticus (SE) is widely recognized as the second most common life-threatening neurological emergency after stroke, which carries a high mortality and morbidity. The main goal of treatment is to emergently stop clinical and electrographic seizure activity. Most authorities agree on three-line treatment for SE with administration of benzodiazepines followed by longer-acting anti-epileptic agents and finally, if seizures persist, the administration of general anaesthetic agents.

引用

页码：85 / 88

页数：4